Psychotropic medication use in early pregnancy: impacts on child socio‐emotional and behavioral development
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Clinical symptoms of distress (anxiety or depression) affect around 10%-25% of women during the perinatal period, which, if left untreated, can adversely affect both maternal health and child development. Psychotropic medications are often first-line treatments for maternal distress in pregnancy, but their effects on child socio-emotional development remain underexplored. This study aims to compare socio-emotional and behavioral development of children at 18 and 36 months according to early pregnancy exposure to treated or untreated maternal distress. METHODS: This project is based on the Montreal Antenatal Well-Being Study, a prospective cohort study of 1,130 pregnant individuals from Quebec, Canada. Women self-reported their medication use and were categorized as: (1) Untreated maternal distress, (2) Psychotropic medication use, (3) Control group (no maternal distress, no psychotropic medication). Analyses of covariance were used to examine the associations between exposure groups and indices of child socio-emotional and behavioral development, assessed using the Early Childhood Behavior Questionnaire and the Child Behavior Checklist. To better account for baseline symptom severity and treatment indication, propensity score weighting was used to create comparable groups with balanced covariates such as socioeconomic status and health care access. RESULTS: Approximately 9.4% of women reported psychotropic medication use in early pregnancy. Analyses of covariance showed that maternal psychotropic medication use was associated with child inhibited temperament at 18 months and greater social withdrawal at 36 months. Propensity weighting revealed that these associations were largely driven by unmeasured confounding, showing no lasting associations with medication. In contrast, children born to mothers with untreated distress had poorer socio-emotional development. CONCLUSIONS: Our findings underscore the critical importance of appropriate statistical control of confounding in observational studies of maternal medication use and child outcomes. They also emphasize the impact of maternal distress on child development and the need for access to effective perinatal treatments.
DOI: 10.1111/jcpp.70255
Institutions: Research Institute of the McGill University Health Centre, McGill University, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Douglas Mental Health University Institute, University of British Columbia, Women's Health Research Institute, B.C. Women's Hospital & Health Centre, BC Children's Hospital Research Institute, Women's College Hospital, Women’s College Hospital Research and Innovation Institute, Yale University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,530
Funders: Brain and Behavior Research Foundation, Canadian Institute for Advanced Research, McGill University, Children's Hospital Foundation, Centre hospitalier universitaire Sainte-Justine, Canada First Research Excellence Fund, Fondation de l'Hôpital de Montréal pour enfants, Fonds de recherche du Québec, Ludmer Centre for Neuroinformatics and Mental Health
Award: G6910506812
OpenAlex ID: W7235189250
